Howard Florey Institute of Experimental Physiology and Medicine

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 6130
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 5120
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 3164
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9359422 Single chain relaxin polypeptidesSep 08, 11Jun 07, 16[A61K, C07H, C07K]
9056922 Chimeric relaxin polypeptides comprising an A and B chain derived from different relaxin family peptidesOct 30, 08Jun 16, 15[A61K, C07K]
8841254 Method for treatment of anxietyAug 21, 07Sep 23, 14[A61K, C07K]
6265156 Hybridization histochemistry method for determining the presence and location in animal or plant tissue of RNAJul 07, 97Jul 24, 01[C12Q]
6013434 Oligonucleotide-polyamide conjugatesFeb 09, 95Jan 11, 00[C12Q]
5843646 DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptidesOct 17, 94Dec 01, 98[C07H, C12Q, C12N, C07K]
5677440 Oligonucleotide-polyamide conjugatesFeb 09, 96Oct 14, 97[C07H]
5597692 Hybridization histochemistry method for determining the presence and location in animal or plant tissue of RNADec 30, 88Jan 28, 97[C12Q]
5552540 Nucleoside derivativesMay 27, 93Sep 03, 96[C07H]
5525465 Oligonucleotide-polyamide conjugates and methods of production and applications of the sameJan 03, 95Jun 11, 96[C07H, C12Q, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0024,592 Modified Relaxin PolypeptidesAbandonedSep 08, 11Jan 23, 14[A61K]
2011/0064,669 USE OF GALANIN IN A METHOD OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONSAbandonedJul 02, 10Mar 17, 11[A61K, A61B, A61P]
2011/0003,750 HUMAN 3 RELAXINAbandonedAug 08, 09Jan 06, 11[A61K, A61P]
2009/0304,818 METHOD OF TREATMENTAbandonedDec 20, 06Dec 10, 09[A61K, A61P]
2009/0239,805 HUMAN 3 RELAXINAbandonedMar 27, 09Sep 24, 09[A61K]
2009/0054,307 PROPHYLACTIC AND THERAPEUTIC AGENTS AND USES THEREFORAbandonedSep 01, 06Feb 26, 09[A61K, C12Q, A61P]
2008/0194,636 Enzyme Inhibitors and Uses ThereofAbandonedSep 09, 05Aug 14, 08[A61K, C12Q, C12N, A61P]
2007/0037,883 Therapeutic compositionsAbandonedSep 14, 04Feb 15, 07[A61K]
2007/0004,619 Relaxin superfamily peptide analoguesAbandonedJun 18, 04Jan 04, 07[A61K]
2005/0026,822 Human 3 relaxinAbandonedSep 29, 04Feb 03, 05[A61K]
2005/0020,519 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activityAbandonedSep 10, 04Jan 27, 05[A61K, C12Q, G01N]
5846728 Oligonucleotide-polyamide conjugatesExpiredOct 27, 97Dec 08, 98[C12Q, C12P]
5053488 Molecular cloning and characterization of a gene sequence coding for human relaxinExpiredJul 06, 90Oct 01, 91[C07K]
5023321 Molecular cloning and characterization of a further gene sequence coding for human relaxinExpiredMar 04, 87Jun 11, 91[C07K]
4871670 Molecular cloning and characterization of a gene sequence coding for human relaxinExpiredMay 12, 86Oct 03, 89[C07H, C12N]
4758516 Molecular cloning and characterization of a further gene sequence coding for human relaxinExpiredDec 13, 83Jul 19, 88[C07H, C12P, C12N]
4656249 Peptides with relaxin activityExpiredJun 10, 82Apr 07, 87[C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.